A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: Cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II)

Archives of Pediatrics and Adolescent Medicine

Volumn 159, Issue 5, 2005, Pages 428-434

  Sullivan, Sean D ^a   Lee, Todd A ^c,d,e   Blough, David K ^a   Finkelstein, Jonathan A ^f   Lozano, Paula ^b,g   Inui, Thomas S ^h   Fuhlbrigge, Anne L ^f   Carey, Vincent J ^f   Wagner, Ed ^g   Weiss, Kevin B ^c,d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c HINES VA HOSPITAL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Chicago College of Pharmacy   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g CENTER FOR HEALTH STUDIES   (United States)

^h REGENSTRIEF INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLXANTHINE DERIVATIVE;

ADOLESCENT; ARTICLE; ASTHMA; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DECISION MAKING; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MULTICENTER STUDY; ORGANIZATION; PHYSICIAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; COST-BENEFIT ANALYSIS; EDUCATION, MEDICAL, CONTINUING; FEMALE; HOSPITALIZATION; HUMANS; MALE; MANAGED CARE PROGRAMS; PEDIATRICS; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 20944435838     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.159.5.428     Document Type: Article

References (26)

1. Weiss KB, Lozano P, Finkelstein JA, et al. A randomized controlled clinical trial to improve asthma care for children through provider education and health systems change: a description of the Pediatric Asthma Care Patient Outcomes Research Team (PAC-PORT II) study design. Health Serv Outcomes Res Method. In press.
2. Bolton MB, Tilley BC, Kuder J, Reeves T, Schultz LR. The cost and effectiveness of an education program for adults who have asthma. J Gen Intern Med. 1991; 6:401-407.
3. Kelly CS, Morrow AL, Shults J, et al. Outcomes evaluation of a comprehensive intervention program for asthmatic children enrolled in Medicaid. Pediatrics. 2000; 105:1029-1035.
4. Kelso TM, Self TH, Rumbak MJ, et al. Educational and long-term therapeutic intervention in the ED: effect on outcomes in adult indigent minority asthmatics. Am J Emerg Med. 1995;13:632-637.
5. Mayo PH, Richman J, Harris HW. Results of a program to reduce admissions for adult asthma. Ann Intern Med. 1990;112:864-871.
6. Lozano P, Finkelstein JA, Carey VJ, et al. A multi-site randomized trial of the effects of physician education and organizational change in chronic asthma care: health outcomes of the Pediatric Asthma Care PORT study. Arch Pediatr Molesc Med. 2004;158:875-883.
7. Sullivan SD, Buxton M, Andersson LF, et al. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol. 2003;112:1229-1236.
8. Sullivan SD, Weiss KB, Lynn H, et al. The cost-effectiveness of an inner-city asthma intervention for children. J Allergy Clin Immunol. 2002;110:576-581.
9. Gendo K, Sullivan SD, Lozano P, et al. Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol. 2003; 91:251-257.
10. National Institutes of Health National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute; 1997. NIH publication 97-4051.
11. Sullivan S, Elixhauser A, Buist AS, Luce BR, Eisenberg J, Weiss KB. National Asthma Education and Prevention Program Working Group report on the cost effectiveness of asthma care. Am J Respir Crit Care Med. 1996;154:S84-S95.
12. Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000;106:493-499.
13. Bureau of Labor Statistics, US Department of Labor. National wage rate, 2002. Available at: http://www.bls.gov/bls/blswage.htm. Accessed March 14, 2004.
14. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997;6:327-340.
15. Hoch JS, Briggs AH, Willan AR. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ. 2002;11:415-430.
16. Bryce FP, Neville RG, Crombie IK, Clark RA, McKenzie P. Controlled trial of an audit facilitator in diagnosis and treatment of childhood asthma in general practice. BMJ. 1995;310:838-842.
17. Gallefoss F, Bakke PS. Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial. Eur Respir J. 2001;17:206-213.
18. Greineder DK, Loane KC, Parks P. Reduction in resource utilization by an asthma outreach program. Arch Pediatr Adolesc Med. 1995;149:415-420.
19. Greineder DK, Loane KC, Parks P. A randomized controlled trial of a pediatric asthma outreach program. J Allergy Clin Immunol. 1999;103:436-440.
20. Wilson SR, Scamagas P, German DF, et al. A controlled trial of two forms of self-management education for adults with asthma. Am J Med. 1993;94:564-576.
21. Rutten-Van Molken MP, Van Doorslaer EK, Jansen MC, Essen-Zandvliet EE, Rutten FF. Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma. Pharmacoeconomics. 1993;4:257-270.
22. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996.
23. Lozano P, Sullivan SD, Smith DH, Weiss KB. The economic burden of asthma in US children: estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol. 1999;104:957-963.
24. Lee TA, Weiss KB. Preference assessment in patients with asthma. Expert Rev Pharmacoecon Outcomes Res. 2002;2:89-100.
25. Paltiel AD, Fuhlbrigge AL, Kitch BT, et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the asthma policy model. J Allergy Clin Immunol. 2001;108:39-49.
26. Lee TA, Hollingworth W, Sullivan SD. Comparison of directly elicited preferences to preferences derived from the SF-36 in adults with asthma. Med Decis Making. 2003;23:323-334.